
AstraZeneca and Bristol Myers Squibb in Talks for $400 Billion Mega-Merger
AstraZeneca and Bristol Myers Squibb have held preliminary discussions about a potential merger valued at approximately $400 billion, a deal that would create one of the world's largest pharmaceutical companies but faces.

